Board of Directors
- Mr Iain Kirkwood (Non-Executive Chairman)
- Mr Bruce Hewett (Non-Executive Director)
- Mr Allan Tan (Non-Executive Director)
Mr Iain Kirkwood (Non-Executive Chairman)
Mr Kirkwood joined the Board on 9 August 2010 as a Non-Executive Director of the Company. On the resignation of Mr Joe Baini on the 18th April 2011 the Avexa Board unamimously resolved to appoint Mr Iain Kirkwood the new Chairman of Avexa from that date. Mr Kirkwood is also the Chairman of the Avexa Audit Committee and a member of the Avexa Remuneration and Nomination Committee. He has extensive operational, financial, general management and boardroom experience, particularly in the life sciences industry.
He is currently serving as a Non-Executive Director on the Boards of Medical Developments International Ltd. (ASX.MVP), Vision Group Holdings Ltd. (ASX.VGH) and Broadvector Ltd, a life sciences company seeking an ASX listing. He is a seed investor in start-up companies bluechiip Ltd. and Celvis Ltd and continues to serve on the Board of these companies and plays an active role in the life science and healthcare sector.
During his career Mr Kirkwood has worked with a number of ASX listed companies in senior management roles, including Woodside Petroleum Ltd. and Santos Ltd, and was previously the CFO of F.H. Faulding & Co. Ltd. and CEO of EpiTan Ltd. (now Clinuvel Pharmaceuticals Ltd).Mr Bruce Hewett (Non-Executive Director)
Mr Hewett joined the Board on 7 July 2010 as a Non-Executive Director of the Company and brings more than 25 years experience in the pharmaceutical and healthcare industries. He is a Director of private pharmaceutical companies Lupin Australia Pty Ltd and Equity Pharmaceuticals Pty Ltd. Mr Hewett has held senior roles with Janssen-Cilag, Faulding Pharmaceuticals and founded specialist pharmaceutical company Max Pharma.Mr Allan Tan (Non-Executive Director)
Mr. Allan Tan joined the board on 30 November 2010 as a non executive director. Mr. Tan has been a corporate lawyer for over 15 years and has wide-ranging experience in corporate and commercial law. He is a key partner at Singapore law firm Colin Ng & Partnersâ?? corporate finance and compliance & regulatory practice. Mr. Tan is also currently an independent director of Singapore listed company, Adventus Holdings Limited, where he is chairman of its Remuneration and Nominating Committees.
